Recently, the Management Committee of Yong'an Nige Development Zone and Fujian Huayao Biotechnology Co., Ltd. officially signed an agreement. Huayao Biotechnology will invest 360 million yuan to build an biomedical production line in the northern industrial new city of Yong'an City, and develop a series of products such as 10,000 tons of pharmaceutical intermediates per year.
▲Huang Youwei, director of Nige Development Zone, signed an investment agreement with Li Caihua, chairman of Fujian Huayao Biotechnology Co., Ltd.
Zhejiang Huaji Biotechnology Co., Ltd., the investor of Fujian Huayao Biotechnology Co., Ltd., is a technology-based enterprise supported by high-tech. It mainly engages in the research and development and sales of biological raw materials and bioengineering technology. The company has broad development prospects.
Huayao Bio is located in Yong'an North New City. It is a project jointly organized by Yong'an Municipal People's Congress, Cultural Entrepreneurship Park, and Nige Development Zone. It is also the result of Yong'an City's implementation of collaborative investment and shared investment.
This year, Yong'an City has promoted high-quality economic development with high-quality investment promotion, established the idea of "one game of chess in the whole city" in project introduction, and carried out collaborative investment promotion and targeted investment promotion in accordance with the location characteristics, resource endowment, industrial foundation, environmental capacity and other industrial characteristics of different development zones. Various departments and parks have formed an investment promotion cooperation mechanism of "information sharing and resource sharing".
(Lai Changchun)